Bibliometric and visual analysis in the field of two-dimensions nano black phosphorus in cancer from 2015 to 2023
View abstract on PubMed
Summary
This summary is machine-generated.Research on Two-Dimensional Nano Black Phosphorus (2D nano BP) for cancer treatment shows increasing global interest. This nanomaterial shows significant promise in drug delivery, photothermal, and photodynamic therapies.
Area Of Science
- Nanomaterials Science
- Oncology Research
- Biomedical Engineering
Background
- Two-Dimensional Nano Black Phosphorus (2D nano BP) is an emerging material with unique properties.
- Its application in cancer research has gained traction due to its potential therapeutic benefits.
Purpose Of The Study
- To comprehensively summarize the status and trends of 2D nano BP in cancer research from 2015 to 2023.
- To provide insights for future research directions in this field.
- To identify key players and research focuses.
Main Methods
- Bibliometric analysis of 446 articles from the Web of Science database (2015-2023).
- Utilized R and VOSviewer software for data analysis.
- Identified publication trends, leading countries, prominent journals, key researchers, and common keywords.
Main Results
- Consistent increase in publication rates observed, particularly between 2017-2019.
- China leads in publication volume and international collaborations.
- Key research areas include drug delivery, photothermal therapy, photodynamic therapy, and immunotherapy.
- Prominent journals: ACS Applied Materials & Interfaces, Advanced Materials. Key researchers: Zhang Han, Tao Wei, Yu Xuefeng.
Conclusions
- 2D nano BP demonstrates significant promise for advancing cancer treatment strategies.
- Global research interest in 2D nano BP for oncology is growing.
- This study serves as a valuable reference for future investigations in this rapidly developing field.
Related Concept Videos
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

